bibliographicCitation |
Melancon BJ, Lamers AP, Bridges TM, Sulikowski GA, Utley TJ, Sheffler DJ, Noetzel MJ, Morrison RD, Scott Daniels J, Niswender CM, Jones CK, Jeffrey Conn P, Lindsley CW, Wood MR. Development of a more highly selective M1 antagonist from the continued optimization of the MLPCN Probe ML012. Bioorganic & Medicinal Chemistry Letters. 2012 Jan;22(2):1044–8. doi: 10.1016/j.bmcl.2011.11.110. |